EXECUTIVE ENGAGEMENTS
OUTREACH
7311
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
1024
Interactions with Platform & by Email
PARTICIPANTS
219
Unique # Participated
VALIDATIONS
99
Responses Validated*
COMPETITORS
92
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
297
PAGES
419
EDITION
16
PRICE
USD $5600
HIGHLIGHTS
Amid the COVID-19 crisis, the global market for Contraceptives estimated at US$21.7 Billion in the year 2020, is projected to reach a revised size of US$29.1 Billion by 2027, growing at aCAGR of 4.3% over the period 2020-2027. Drugs, one of the segments analyzed in the report, is projected to record 4.6% CAGR and reach US$18.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Devices segment is readjusted to a revised 3.7% CAGR for the next 7-year period.
The Contraceptives market in the U.S. is estimated at US$5.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.3 Billion by the year 2027 trailing a CAGR of 7.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.4% and 3.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.2% CAGR.
SELECT PLAYERS
Agile Therapeutics, Inc.; Allergan plc; Ansell Limited; Bayer AG; Church & Dwight Co., Inc.; CooperSurgical Inc.; Fuji Latex Co. Ltd.; Janssen Pharmaceuticals, Inc.; Karex Berhad; Mankind Pharma Ltd.; Okamoto Industries, Inc.; Pfizer Inc.; Piramal Enterprises Ltd.; Reckitt Benckiser Group Plc.; Sagami Rubber Industries Co., Ltd.; Teva Pharmaceutical Industries Ltd.; Thai Nippon Rubber Industry Co., Ltd.
SEGMENTS
» Product Type (Drugs, Devices) » Gender (Female, Male) » End-Use (Household, Hospitals, Clinics)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| Contraceptives: Transforming Birth Control, Planned Parenthood, and Women’s Health |
| Contraceptives Market: Fast Facts |
| The Vital Need to Curtail the Ballooning Global Population through Birth Control: |
| Effectiveness Index of Contraceptive Methods: Brief Details of Method, Efficacy Percentage, Benefits, Risks, and Availability |
| Unmet Contraception Needs Signals Huge Market Penetration Opportunities |
| Global Population Statistics: Unfurling the Market Potential |
| China & India: Two Countries with the Largest Sexually Active Population Offer Significant Growth Opportunities |
| Global Market Outlook |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| Condoms as a Powerful Tool against HIV/AIDS and Other STIs Witness Strong Growth in Demand |
| Condoms: Percentage Effectiveness of Protection against STDs |
| Contraceptive Innovations and Advancements: Spearheading Growth |
| Major Condom Innovations |
| Declining Prices and Increased Accessibility of Contraceptives Benefit Market Expansion |
| Despite Waning Popularity, Oral Contraceptives Continue to Sustain Market Domination |
| Rising Need to Develop Contraceptives for Men Drive Robust Research & Development |
| Evolving Designs and Features in Female Condoms Drive Surging Popularity and Growing Adoption |
| Increasing Standard of Living: A Key Growth Driver |
| Social Stigmas in Under Developed Countries Hamper Market Prospects |
| Major Hindrances for Widespread Usages of Condoms |
| Developing Countries Continue to Drive Current and Future Market Growth |
| Manufacturers Depend on Emerging Markets to Increase Sales Momentum |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Contraceptives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Contraceptives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Contraceptives by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Female by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Female by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Female by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Male by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Male by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Male by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Household by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Household by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Household by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Contraceptives by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Contraceptives by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Contraceptives by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| SPAIN |
| Spain Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Spain Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Spain Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| RUSSIA |
| Russia Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Russia Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Russia Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Contraceptives by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Contraceptives by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Contraceptives by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| AUSTRALIA |
| Australia Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Australia 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Australia Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Australia 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Australia Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Australia 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| INDIA |
| India Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| India Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| India 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| India Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| India Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| India 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| India Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| India Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| India 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| SOUTH KOREA |
| South Korea Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| South Korea 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| South Korea Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| South Korea 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| South Korea Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| South Korea 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| REST OF ASIA-PACIFIC |
| Rest of Asia-Pacific Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Rest of Asia-Pacific Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Rest of Asia-Pacific Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| LATIN AMERICA |
| Latin America Current & Future Analysis for Contraceptives by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Contraceptives by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Contraceptives by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027 |
| Latin America Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Latin America Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Latin America Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| ARGENTINA |
| Argentina Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Argentina 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Argentina Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Argentina 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Argentina Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Argentina 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| BRAZIL |
| Brazil Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Brazil 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Brazil Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Brazil 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Brazil Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Brazil 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| MEXICO |
| Mexico Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Mexico 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Mexico Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Mexico 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Mexico Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Mexico 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| REST OF LATIN AMERICA |
| Rest of Latin America Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Latin America 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Rest of Latin America Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Latin America 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Rest of Latin America Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Latin America 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| MIDDLE EAST |
| Middle East Current & Future Analysis for Contraceptives by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Contraceptives by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Contraceptives by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027 |
| Middle East Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Middle East Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Middle East Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| IRAN |
| Iran Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Iran 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Iran Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Iran 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Iran Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Iran 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| ISRAEL |
| Israel Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Israel 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Israel Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Israel 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Israel Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Israel 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| SAUDI ARABIA |
| Saudi Arabia Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Saudi Arabia 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Saudi Arabia Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Saudi Arabia 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Saudi Arabia Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Saudi Arabia 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| UNITED ARAB EMIRATES |
| UAE Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UAE 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| UAE Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UAE 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| UAE Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UAE 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| REST OF MIDDLE EAST |
| Rest of Middle East Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Middle East 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Rest of Middle East Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Middle East 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Rest of Middle East Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Middle East 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| AFRICA |
| Africa Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 |
| Africa Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2012, 2020 & 2027 |
| Africa Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 92 |
Tapping into New Geographical Markets is a Great Way to Grow!
What's Your Addressable Opportunity in the Contraceptives Market?
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com